By: Communications
This Women’s Health Month, HealthUEA has invited experts from across the University to explore various aspects of this field. These valuable insights from our researchers will help to increase public knowledge in an area of study which has historically been under-researched and under-discussed.
In the collection, Dr Jo Bower (School of Psychology) investigates the effects of the menstrual cycle on sleep. She describes how the higher prevalence in insomnia amongst women, compared to men, has a detrimental effect on positive emotions, suggesting that mood disorders may be connected to the menstrual cycle through both changes in sleep as well as hormones.
Dr Lorna Richardson (School of Art, Media and American Studies) looks back at her research into the online expression of endometriosis pain. She highlights the support network provided by forums such as Reddit, where communities come together in subreddits to share their experiences.
Elsewhere in the collection, Dr Rita Issa (School of Global Development) discusses the relationship between extreme weather events and gender-based violence, exposing the increasing frequency of violence after natural disasters and its effect on various aspects of women’s health.
Adding context to her lecture on ‘Menopause for All’, Prof Anne-Marie Minihane (Norwich Medical School), answers questions about the menopausal transition, shining a light on its effects and treatment, and the societal and governmental handling of this much misunderstood life stage.
The ‘Understanding Women’s Health’ collection highlights the incredible research being undertaken in this field at UEA. Explore the collection.
Offering rewards helps people to stop smoking, with success rates continuing long after incentives have stopped.
Read moreResearch published today could help neurologists in the future prescribe personalised treatment to people living with multiple sclerosis (MS), after scientists studied more than half a million brain cells.
Read moreUEA researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care.
Read more